Chinese Herbal Medicine (Weijing Decoction) Combined with Pharmacotherapy for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Objective. To evaluate the efficacy and safety of Weijing decoction combined with routine
pharmacotherapy (RP) for the treatment of acute exacerbations of chronic obstructive
pulmonary disease (AECOPD). Methods. Randomized controlled trials (RCT) evaluating
Weijing decoction for AECOPD were included. English, Chinese, and Japanese databases
were searched from their respective inceptions to June 2013. The methodological quality
was assessed according to the Cochrane Collaboration's risk of bias tool. All data were …
pharmacotherapy (RP) for the treatment of acute exacerbations of chronic obstructive
pulmonary disease (AECOPD). Methods. Randomized controlled trials (RCT) evaluating
Weijing decoction for AECOPD were included. English, Chinese, and Japanese databases
were searched from their respective inceptions to June 2013. The methodological quality
was assessed according to the Cochrane Collaboration's risk of bias tool. All data were …
Chinese herbal medicine (Weijing decoction) combined with pharmacotherapy for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
LSN Liu ShaoNan, J Shergis, CXK Chen XianKun… - 2014 - cabidigitallibrary.org
Objective. To evaluate the efficacy and safety of Weijing decoction combined with routine
pharmacotherapy (RP) for the treatment of acute exacerbations of chronic obstructive
pulmonary disease (AECOPD). Methods. Randomized controlled trials (RCT) evaluating
Weijing decoction for AECOPD were included. English, Chinese, and Japanese databases
were searched from their respective inceptions to June 2013. The methodological quality
was assessed according to the Cochrane Collaboration's risk of bias tool. All data were …
pharmacotherapy (RP) for the treatment of acute exacerbations of chronic obstructive
pulmonary disease (AECOPD). Methods. Randomized controlled trials (RCT) evaluating
Weijing decoction for AECOPD were included. English, Chinese, and Japanese databases
were searched from their respective inceptions to June 2013. The methodological quality
was assessed according to the Cochrane Collaboration's risk of bias tool. All data were …
以上显示的是最相近的搜索结果。 查看全部搜索结果